Investigating spatiotemporal and kinematic gait parameters in individuals with Parkinson's disease with a history of freezing of gait and exploring the effects of dopaminergic therapy on freezing of gait subtypes

被引:0
|
作者
Lin, Po-Hsi [1 ]
Lai, Yun-Ru [1 ,2 ]
Lien, Chia-Yi [1 ]
Huang, Chih-Cheng [1 ]
Chiang, Yi-Fang [1 ]
Kung, Chien-Feng [3 ]
Chen, Chih-Jui [4 ]
Lu, Cheng-Hsien [1 ,5 ,6 ,7 ]
机构
[1] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Coll Med, Kaohsiung, Taiwan
[2] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Hyperbar Oxygen Therapy Ctr, Coll Med, Kaohsiung, Taiwan
[3] Natl Kaohsiung Univ Sci & Technol, Dept Intelligent Commerce, Kaohsiung, Taiwan
[4] LongGood Meditech Ltd, Taipei, Taiwan
[5] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Coll Med, Kaohsiung, Taiwan
[6] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan
[7] Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen, Peoples R China
关键词
freezing of gait; kinematics; levodopa-unresponsive; levodoparesponsive; Parkinson's disease; spatiotemporal parameters; LEVODOPA;
D O I
10.3389/fnins.2024.1404613
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction Freezing of Gait (FOG) is a prevalent and debilitating symptom in idiopathic Parkinson's disease (PD). This study evaluated spatiotemporal and kinematic gait parameters in individuals with PD with a history of FOG and explored the effects of dopaminergic therapy on FOG subtypes. Methods One hundred and nine individuals with PD underwent clinical assessments and quantitative biomechanical measures during walking cycles before and after dopaminergic therapy. Individuals with FOG were classified into levodopa-responsive and levodopa-unresponsive groups. Results Individuals with FOG displayed longer disease duration and higher Unified Parkinson's Disease Rating Scale (UPDRS) II, III, IV scores, and total scores and levodopa equivalent dose, than those without FOG (all p < 0.0001). Following propensity score matching of 15 pairs based on UPDRS total score and disease duration during the off-medication state, the analysis comparing the FOG and non-FOG groups revealed no significant differences in spatiotemporal and kinematic parameters. In 39 cases of FOG, dopaminergic therapy improved gait performance in individuals with PD, enhancing spatiotemporal parameters (speed, stride length, step length, step variability) and kinematic parameters (shoulder and elbow flexion/extension range of motion (ROM), pelvic rotation, and hip abduction/adduction ROM) regardless of FOG responsiveness to dopaminergic therapy. A significant difference in trunk sway ROM (p = 0.029) remained before and after dopaminergic therapy, even after adjusting for disease duration and clinical severity. Discussion Dopaminergic therapy had varying effects on PD with FOG, improving several spatiotemporal and kinematic gait parameters but being less effective in levodopa-unresponsive cases. Quantitative biomechanical measures offer detailed insights into gait performance, aiding personalized fall risk assessment and guiding individualized rehabilitation programs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effects of Parkinson's disease and freezing of gait on the kinematic and kinetic gait parameters
    Campos, D.
    Shida, T.
    Oliveira, C.
    Treza, R.
    Hondo, S.
    Los Angeles, E.
    Bernardo, C.
    Oliveira, L.
    Carvalho, M.
    Coelho, D.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S321 - S321
  • [2] Evidence for Subtypes of Freezing of Gait in Parkinson's Disease
    Martens, Kaylena A. Ehgoetz
    Shine, James M.
    Walton, Courtney C.
    Georgiades, Matthew J.
    Gilat, Moran
    Hall, Julie M.
    Muller, Alana J.
    Szeto, Jennifer Y. Y.
    Lewis, Simon J. G.
    [J]. MOVEMENT DISORDERS, 2018, 33 (07) : 1174 - 1178
  • [3] Argentine tango effects on balance and gait in Parkinson's disease: Individuals with and without freezing of gait and fall history
    Hackney, M. E.
    Earhart, G. M.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S297 - S298
  • [4] The effects of gait impairment with and without freezing of gait in Parkinson's disease
    Finkbiner, A. P.
    Gruber-Baldini, A. L.
    Anderson, K. E.
    Fishman, P. S.
    Weiner, W. J.
    Reich, S. R.
    Shulman, L. M.
    [J]. MOVEMENT DISORDERS, 2008, 23 (11) : 1632 - 1633
  • [5] The effects of gait impairment with and without disease freezing of gait in Parkinson's disease
    Josiah, Anne F.
    Gruber-Baldini, Ann L.
    Anderson, Karen E.
    Fishman, Paul S.
    Weiner, William J.
    Reich, Stephen G.
    Shulman, Lisa M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2012, 18 (03) : 239 - 242
  • [6] Freezing of gait in Parkinson's disease
    Giladi, N
    McDermott, M
    Fahn, S
    Przedborski, S
    [J]. NEUROLOGY, 1996, 46 (02) : 5130 - 5130
  • [7] Freezing of gait subtypes have different Parkinson's disease
    Factor, S. A.
    Scullin, M. K.
    Sollinger, A. B.
    Land, J. O.
    Wood-Siverio, C.
    Zanders, L.
    Freeman, A.
    Bliwise, D. L.
    Goldstein, F. C.
    [J]. PARKINSONISM & RELATED DISORDERS, 2014, 20 (12) : 1359 - 1364
  • [8] Freezing gait in Parkinson's disease
    Lamberti, P
    Armenise, S
    Castaldo, V
    de Mari, M
    Iliceto, G
    Tronci, P
    Serlenga, L
    [J]. EUROPEAN NEUROLOGY, 1997, 38 (04) : 297 - 301
  • [9] Freezing of gait in Parkinson's disease
    Panisset, M
    [J]. NEUROLOGIC CLINICS, 2004, 22 (03) : S53 - S62
  • [10] Freezing of gait in Parkinson’s disease
    Yasuyuki Okuma
    [J]. Journal of Neurology, 2006, 253 : vii27 - vii32